Company news
Aclarion, Inc. news in 2024
Aclarion, Inc.'s news releases, calls and decks from 2024, newest first.
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
November 20, 2024
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
September 26, 2024
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
September 11, 2024
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
September 9, 2024
Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
September 4, 2024
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
August 28, 2024
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
August 20, 2024
Aclarion Announces First Commercial Agreement in Michigan
August 13, 2024
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
August 12, 2024
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
July 8, 2024
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
June 25, 2024
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
June 24, 2024
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
June 19, 2024
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
June 17, 2024
Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
April 24, 2024
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
March 3, 2024
Aclarion Announces Closing of $3.0 Million Public Offering
February 26, 2024
Aclarion Announces Pricing of $3.0 Million Public Offering
February 25, 2024
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
February 4, 2024
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
January 21, 2024
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution
January 16, 2024
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
January 7, 2024